Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld®, Contrary to 8 Prior Main Variant of Concern (VOC) - Aix-Marseille Université Access content directly
Journal Articles Clinical Infectious Diseases Year : 2022

Dates and versions

hal-03683548 , version 1 (31-05-2022)

Identifiers

Cite

Céline Boschi, Philippe Colson, Audrey Bancod, Valérie Moal, Bernard La Scola. Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld®, Contrary to 8 Prior Main Variant of Concern (VOC). Clinical Infectious Diseases, 2022, ⟨10.1093/cid/ciac143⟩. ⟨hal-03683548⟩

Collections

CNRS UNIV-AMU ANR
13 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More